ROBERT STRONG: Open Payments
NPI 1740370378 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$97 in 5 payments from 4 companies in 2025. Trend: 2023 $16 · 2024 $25 · 2025 $97
Food & beverage: $97
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| ABBVIE INC. | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: REXULTI, VRAYLAR, INGREZZA, AUSTEDO XR.
Industry payments across UT — which companies pay providers there.
